Results 161 to 170 of about 47,933 (260)
Omalizumab demonstrates efficacy and safety in Chinese children under 12 with chronic urticaria: a case series. [PDF]
Zhao H, Luo L, Jia WM.
europepmc +1 more source
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud +14 more
wiley +1 more source
Serum Neuropeptides in Chronic Spontaneous Urticaria: Associations With Disease Activity and Clinical Phenotypes. [PDF]
Shi Z, Deng X, Ren J, Lu S, Tan G.
europepmc +1 more source
Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres +19 more
wiley +1 more source
Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE study. [PDF]
Calzavara-Pinton P +13 more
europepmc +1 more source
This observational analysis of a consecutive tertiary‐care cohort included 70 patients with walnut allergy and 44 patients with hazelnut allergy. Clinical severity was classified as mild, moderate, or severe. Hazelnut and walnut allergy severity was better captured by molecule‐specific IgE profiles than by undifferentiated seed storage protein ...
Danilo Villalta +14 more
wiley +1 more source
Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care. [PDF]
Topa E +9 more
europepmc +1 more source
ABSTRACT Allergen immunotherapy (AIT) has been acknowledged as the only disease‐modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study results may vary substantially.
Roy Gerth van Wijk +10 more
wiley +1 more source
A Cautionary Tale: Urticaria and Angioedema As Presenting Signs of Lymphoproliferative Disorders. [PDF]
Kafashzadeh D, Kachru R.
europepmc +1 more source

